Katerzia (amlodipine) Oral Suspension Approved for Pediatric Patients 6 Years of Age and Older

By :

New Ebola Vaccine for Exposure Risk

Azurity Pharmaceuticals, a specialty pharmaceutical company that makes safe, high-quality treatments for patients requiring customized formulations for their care, announced today that the U.S. Food and Drug Administration (FDA) has approved Katerzia (#amlodipine) Oral Suspension, 1 mg/mL, the first and only FDA-approved amlodipine oral suspension. Katerzia is indicated for the treatment of #hypertension (high blood pressure) in adults and pediatric patients 6 years of age and older and coronary artery disease in adults. “We are pleased to announce the #FDA approval of Katerzia”, said Neal Muni, MD, MSPH, President and Chief Executive Officer of Azurity Pharmaceuticals. “The addition of Katerzia complements our existing pediatric hypertension portfolio and will strengthen the overall offering from Azurity. It is also our first product approval since CutisPharma and Silvergate Pharmaceuticals came together to make Azurity Pharmaceuticals, making this a truly exciting time.” Katerzia offers a ready-to-use (simply shake) oral suspension for children 6 years of age and older that require or prefer an oral liquid option of amlodipine. Appropriate dosing for children is now simple, safe, and effective, while providing the assurance of quality as an FDA-approved product. #FDA #Approved #amlodipine
Rate UsDon’t love itNot greatGoodGreatLove itRate Us
Your opinion


Approval of new treatment for adults with partial-onset seizures


Navigating the New Clozapine REMS


LENVIMA (lenvatinib) capsules


FDA approval : first treatment for frequent urination at night


A new eczema drug Dupixent : FDA Approval


New drug that can prevent breast cancer growth identified

© 2019 PHAF  || All rights reserved

  • Facebook Social Icon
  • Twitter Social Icon
  • Google+ Social Icon
  • YouTube Social  Icon
  • Instagram Social Icon

Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a healthcare professional.